Merck says US rejects its MS drug
by on Mar.02, 2011, under Health and Fitness
German pharmaceutical group Merck KgaA said Wednesday that the US Food and Drug Administration (FDA) has refused to approve use of its multiple sclerosis treatment Cladribine.
View full post on Yahoo! Health News